纳米材料驱动精密免疫调节:治疗干预的新范式
Alaa A A Aljabali1, Mohammad A Obeid1, Omar Gammoh2
1Faculty of Pharmacy, Department of Pharmaceutics & Pharmaceutical Technology, Yarmouk University, Irbid 21163, Jordan.
Cancers
|June 19, 2024
概括
纳米材料为先进的免疫疗法提供了精确的免疫系统操纵,增强了针对癌症和自身免疫性疾病的治疗方法,具有有针对性的传递和减少副作用. 这种纳米技术方法有望为免疫相关疾病提供创新的解决方案.
科学领域:
- 免疫学和纳米技术
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
背景情况:
- 免疫疗法是癌症和自身免疫性疾病的快速发展的治疗方式.
- 纳米材料为精确的免疫系统调节,有针对性的传递和增强疗效提供了机会.
- 目前的挑战包括非目标效应和优化免疫调节功能.
研究的目的:
- 审查利用纳米材料用于免疫系统操纵在免疫治疗中的策略.
- 讨论各种纳米材料 (脂质体,聚合物,无机NP) 的设计,机制和应用.
- 解决准确医学中的监管考虑和未来潜力.
主要方法:
- 基于纳米材料的免疫疗法策略的文献综述.
- 对有针对性的传递和受控释放动态的设计原则的分析.
- 讨论在增强癌症疫苗,检查点抑制剂和细胞疗法的应用.
主要成果:
- 纳米材料设计允许精确准免疫细胞和组织,最大限度地减少非准效应.
- 特定的纳米材料可以显著提高现有免疫疗法的疗效.
- 通过先进的纳米材料平台,可以实现受控释放动力学和量身定制的免疫反应.
结论:
- 基于纳米材料的平台具有巨大的潜力,可以彻底改变免疫疗法和以患者为中心的护理.
- 这些系统可以通过提高治疗疗效和减少副作用,显著提高精准医学.
- 优先考虑安全性,定制性和监管合规性对于临床翻译至关重要.
相关概念视频
01:27Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
01:27Cytotoxic T Cells-mediated Immune Response
889
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
889